Literature DB >> 7291727

Arterial-venous plasma concentration differences of six drugs in the dog and rabbit after intravenous administration.

W L Chiou, G Lam, M L Chen, M G Lee.   

Abstract

The arterial blood from the femoral artery and venous blood from the femoral vein wee simultaneously collected following intravenous administration of propranolol, lidocaine, procainamide, furosemide, theophylline and griseofulvin to dogs or rabbits. The preliminary results of arterial-venous (A-V) plasma concentration profiles are reported in this communication. The maximum A/V ratios shortly after a rapid intravenous bolus dose were 277-, 15-, 34-, 33-, 5.4- and 3240-fold, respectively, for the above six drugs. The venous plasma levels were higher than arterial plasma levels during parallel terminal phase by as much as 104, 48, 134, 29, 16, and 47%, respectively, for the above six drugs. These data suggest a very rapid and extensive uptake of the drugs by the sampling tissues (the leg) shortly after dosing. The potential significance of A-V differences in pharmacokinetic and pharmacodynamic studies are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7291727

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  12 in total

1.  Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement.

Authors:  R Mehvar
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differences.

Authors:  Stina Syvänen; Gunnar Blomquist; Lieuwe Appel; Margareta Hammarlund-Udenaes; Bengt Långström; Mats Bergström
Journal:  Eur J Clin Pharmacol       Date:  2006-08-08       Impact factor: 2.953

4.  The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates.

Authors:  B Tuk; M Danhof; J W Mandema
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

5.  Definition of pharmacokinetic parameters: influence of the sampling site.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

6.  Modelling of initial distribution of drugs following intravenous bolus injection.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Blood-brain barrier penetration of zolmitriptan--modelling of positron emission tomography data.

Authors:  Mats Bergström; Roger Yates; Anders Wall; Matts Kågedal; Stina Syvänen; Bengt Långström
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-02       Impact factor: 2.745

Review 8.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

9.  Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.

Authors:  M L Chen; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1983-10

10.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.

Authors:  M L Chen; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1983-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.